{"metadata":{"kernelspec":{"language":"python","display_name":"Python 3","name":"python3"},"language_info":{"name":"python","version":"3.11.13","mimetype":"text/x-python","codemirror_mode":{"name":"ipython","version":3},"pygments_lexer":"ipython3","nbconvert_exporter":"python","file_extension":".py"},"kaggle":{"accelerator":"none","dataSources":[{"sourceId":121144,"databundleVersionId":14484960,"sourceType":"competition"}],"dockerImageVersionId":31192,"isInternetEnabled":true,"language":"python","sourceType":"notebook","isGpuEnabled":false}},"nbformat_minor":4,"nbformat":4,"cells":[{"cell_type":"markdown","source":"# AI Literature Review Agent: Specialised Multi-Agent Research Pipeline\n__________________________________________________________________________\n\nThis project is a submission for the **5-Day AI Agents Intensive Course with Google and Kaggle Capstone Project**, demonstrating the development of a robust, multi-agent system for automating the academic literature review process.\n\n## 1. The Problem\n\nAcademic research requires extensive and time-consuming literature reviews. The process is currently highly manual and inefficient; furthermore, the use of LLMs as an alternative often leads to LLMs hallucinating sources when asked to perform the synthesis task alone.\n\n\n## 2. The Solution\n\nThe solution is a **Sequential Multi-Agent Pipeline** that decomposes the complex task of literature review into five steps. This design leverages the strengths of LLMs for high-level synthesis while enforcing reliability through custom tools. \n\nThe the architecture is designed to address the aforementioned challenges in the following manner:\n\n1. **Ensuring Source Integrity:** Ensuring that the generated review is based only on real papers found via Google Search.\n\n2. **Maintaining Consistency:** Enforcing strict, recurring user preferences (e.g. \"only 2024 papers\") across independent research sessions.\n\n3. **Agent Specialisation:** Separating the strictly functional tasks (filtering, citation) from the creative tasks (synthesis) to ensure accurate tool use.\n\n\n### A. Multi-Agent System (Sequential)\n\nThe workflow is strictly managed by a `SequentialAgent` comprising five distinct, specialised sub_agents::\n\n| Agent Name | Role | Output Key / Data Passed |\n|:---|:---|:---|\n| **OrchestratorAgent** | Processes the user query, retrieves memory, and sets the search plan. | `search_request` |\n| **SearchAndRetrievalAgent** | Executes the Google Search to find raw paper data and abstracts. | `raw_papers_list` |\n| **ProcessingAndFilteringAgent** | Scores and filters papers using the custom relevance tool. | `filtered_papers_list` |\n| **BibliographyAgent** | Calls the `citation_formatter` to pre-format the references. | `bibliography_text` |\n| **SynthesisAgent** | Writes the structured review and appends the pre-formatted bibliography. | `final_literature_review` |\n\n### B. Custom Tools\n\nThe system integrates two custom tools to guarantee accurate output:\n\n1. `citation_formatter` (Used by the `BibliographyAgent` to generate accurate bibliography text, overriding the LLM's tendency to hallucinate citations).\n\n2. `calculate_relevance_score` (Used by the `ProcessingAndFilteringAgent` to automatically score each abstract based on the presence and frequency of keywords (defined based on the user's initial prompt). This consequently eliminates irrelevant papers.)\n\n### C. Sessions & Memory (Long-Term Persistence)\n\n* **Retrieval:** The `OrchestratorAgent` is equipped with the `preload_memory` tool, which searches the memory based on the current user query and embeds past preferences/conversations into the current agent's context.\n\n* **Storage:** The `auto_save_orchestrator_turn_to_memory` callback is triggered after the initial run, ensuring the latest user constraints are saved to the memory bank for use in future, new sessions. The use of **Long-Term Memory** transforms the tool from a single-use one into a personalised research assistant that remembers and automatically applies user-defined constraints (such as publication dates, preferred topics etc.) across subsequent sessions.\n\n## 3. Instructions for Setup (Kaggle Notebook)\n\nThis notebook is designed to run self-contained within the Kaggle environment.\n\n### Prerequisites:\n\n1. **Gemini API Key:** Ensure your Gemini API Key is saved in the Kaggle Secrets manager under the variable name `GOOGLE_API_KEY`.\n\n2. **Internet Access:** Ensure \"Internet\" is enabled in the notebook settings.\n\n### Execution Steps:\n\n1. **Setup Cell:** Run the initial Python cell to load your `GOOGLE_API_KEY`.\n\n2. **Code Cells:** Run all subsequent code cells sequentially to define the agents, tools, and the runner.\n\n3. **Demonstration Cell:** Run the final code cells, which execute the two key sessions:\n\n   * Session 1 (Basic Search)\n   * Session 2 (Recalling)","metadata":{}},{"cell_type":"code","source":"import os\nfrom kaggle_secrets import UserSecretsClient\n\ntry:\n    GOOGLE_API_KEY = UserSecretsClient().get_secret(\"GOOGLE_API_KEY\")\n    os.environ[\"GOOGLE_API_KEY\"] = GOOGLE_API_KEY\n    print(\"âœ… Gemini API key setup complete.\")\nexcept Exception as e:\n    print(\n        f\"ðŸ”‘ Authentication Error: Please make sure you have added 'GOOGLE_API_KEY' to your Kaggle secrets. Details: {e}\"\n    )","metadata":{"_uuid":"8f2839f25d086af736a60e9eeb907d3b93b6e0e5","_cell_guid":"b1076dfc-b9ad-4769-8c92-a6c4dae69d19","trusted":true,"execution":{"iopub.status.busy":"2025-11-29T11:36:08.605032Z","iopub.execute_input":"2025-11-29T11:36:08.605853Z","iopub.status.idle":"2025-11-29T11:36:08.831759Z","shell.execute_reply.started":"2025-11-29T11:36:08.605825Z","shell.execute_reply":"2025-11-29T11:36:08.830832Z"}},"outputs":[{"name":"stdout","text":"âœ… Gemini API key setup complete.\n","output_type":"stream"}],"execution_count":30},{"cell_type":"code","source":"APP_NAME = \"MemoryDemoApp\"\nUSER_ID = \"demo_user\"","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-29T11:36:08.833217Z","iopub.execute_input":"2025-11-29T11:36:08.833461Z","iopub.status.idle":"2025-11-29T11:36:08.837802Z","shell.execute_reply.started":"2025-11-29T11:36:08.833441Z","shell.execute_reply":"2025-11-29T11:36:08.836856Z"}},"outputs":[],"execution_count":31},{"cell_type":"code","source":"from google.adk.agents import Agent, SequentialAgent\nfrom google.adk.models.google_llm import Gemini\nfrom google.adk.runners import InMemoryRunner\nfrom google.adk.tools import google_search\nfrom google.genai import types\nfrom google.adk.plugins.logging_plugin import LoggingPlugin\nfrom google.adk.agents import LlmAgent\nfrom google.adk.models.google_llm import Gemini\nfrom google.adk.runners import Runner\nfrom google.adk.sessions import InMemorySessionService\nfrom google.adk.memory import InMemoryMemoryService\nfrom google.adk.tools import load_memory, preload_memory, FunctionTool\nfrom google.genai import types\n\nfrom typing import List, Dict, Any, Union\nprint(\"âœ… ADK components imported successfully.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-29T11:36:26.612783Z","iopub.execute_input":"2025-11-29T11:36:26.613076Z","iopub.status.idle":"2025-11-29T11:36:26.620800Z","shell.execute_reply.started":"2025-11-29T11:36:26.613050Z","shell.execute_reply":"2025-11-29T11:36:26.619789Z"}},"outputs":[{"name":"stdout","text":"âœ… ADK components imported successfully.\n","output_type":"stream"}],"execution_count":34},{"cell_type":"code","source":"async def auto_save_orchestrator_turn_to_memory(callback_context):\n    \"\"\"\n    Callback function that automatically saves the current session (user prompt\n    and orchestrator's plan) to long-term memory after the agent completes its turn.\n    \"\"\"\n    print(\"ðŸ”‘ Auto-saving Orchestrator turn to MemoryService...\")\n    # Access the memory service and current session via the callback_context\n    await callback_context._invocation_context.memory_service.add_session_to_memory(\n        callback_context._invocation_context.session\n    )","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-29T11:36:26.621652Z","iopub.execute_input":"2025-11-29T11:36:26.622292Z","iopub.status.idle":"2025-11-29T11:36:26.637218Z","shell.execute_reply.started":"2025-11-29T11:36:26.622260Z","shell.execute_reply":"2025-11-29T11:36:26.636172Z"}},"outputs":[],"execution_count":35},{"cell_type":"code","source":"# Custom tool definition\ndef calculate_relevance_score(abstract: str, required_keywords: list[str], penalty_keywords: list[str]) -> int:\n    \"\"\"\n    Calculates a simple relevance score (0-100) based on keyword frequency.\n    Used by the Filtering Agent.\n    \"\"\"\n    score = 50 \n    abstract_lower = abstract.lower()\n    \n    # Reward for required keywords\n    for keyword in required_keywords:\n        if keyword.lower() in abstract_lower:\n            score += 15\n            \n    # Penalty for off-topic keywords\n    for keyword in penalty_keywords:\n        if keyword.lower() in abstract_lower:\n            score -= 25\n            \n    return max(0, min(100, score))\n\nrelevance_tool = FunctionTool(func=calculate_relevance_score\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-29T11:36:26.638156Z","iopub.execute_input":"2025-11-29T11:36:26.638399Z","iopub.status.idle":"2025-11-29T11:36:26.648108Z","shell.execute_reply.started":"2025-11-29T11:36:26.638375Z","shell.execute_reply":"2025-11-29T11:36:26.647210Z"}},"outputs":[],"execution_count":36},{"cell_type":"code","source":"retry_config=types.HttpRetryOptions(\n    attempts=5,  # Maximum retry attempts\n    exp_base=7,  # Delay multiplier\n    initial_delay=1, # Initial delay before first retry (in seconds)\n    http_status_codes=[429, 500, 503, 504] # Retry on these HTTP errors\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-29T11:36:26.649317Z","iopub.execute_input":"2025-11-29T11:36:26.650177Z","iopub.status.idle":"2025-11-29T11:36:26.664327Z","shell.execute_reply.started":"2025-11-29T11:36:26.650153Z","shell.execute_reply":"2025-11-29T11:36:26.663498Z"}},"outputs":[],"execution_count":37},{"cell_type":"code","source":"# 1. Orchestrator Agent (The Planner)\n# Output: Structured JSON request (topic, keywords, off_keywords) for the search agent.\norchestrator_agent = Agent(\n    name=\"OrchestratorAgent\",\n    model=Gemini(\n        model=\"gemini-2.5-flash-lite\",\n        retry_options=retry_config\n    ),\n    instruction=\"\"\"You are a planning expert. \n    You convert the user's literature review request into a structured JSON object containing 'topic', \n    'keywords' (list of 5-8 primary terms), and 'off_keywords' (list of 3 terms to penalize). \n    Your output MUST be ONLY the JSON object. Use past conversation history if available.\"\"\",\n    tools=[load_memory], \n    output_key=\"search_request\",\n    after_agent_callback=auto_save_orchestrator_turn_to_memory\n)\nprint(\"âœ… OrchestratorAgent created.\")\n\n# 2. Search & Retrieval Agent\n# Output: A raw list of academic papers (title, abstract, URL) found online.\nsearch_agent = Agent(\n    name=\"SearchAndRetrievalAgent\",\n    model=Gemini(\n        model=\"gemini-2.5-flash-lite\",\n        retry_options=retry_config\n    ),\n    instruction=\"\"\"You receive a structured search request from the session state. \n    Use the Google Search tool to find 10-15 recent academic papers (titles and abstracts) \n    related to the keywords. Output the results as a clean list of JSON objects, \n    with keys: 'title', 'abstract', and 'url'. Do not include any text outside the JSON list.\"\"\",\n    # Assign the Built-in Google Search Tool here\n    tools=[google_search], \n    output_key=\"raw_papers_list\", # Stores the search results\n)\nprint(\"âœ… SearchAndRetrievalAgent created.\")\n\n# 3. Processing & Filtering Agent\n# Output: A highly-filtered list of relevant papers (score > 70).\nfiltering_agent = Agent(\n    name=\"ProcessingAndFilteringAgent\",\n    model=Gemini(\n        model=\"gemini-2.5-flash-lite\",\n        retry_options=retry_config\n    ),\n    instruction=\"\"\"You receive the 'raw_papers_list' and the 'search_request'. \n    You MUST use the 'relevance_scorer' tool for every abstract. \n    The tool requires the abstract, keywords, and off_keywords. \n    Filter and output ONLY papers with a score above 70. \n    The output must be a JSON list of filtered papers, including the final score.\"\"\",\n    # Assign the Custom Relevance Tool here\n    tools=[relevance_tool], \n    output_key=\"filtered_papers_list\", # Stores the curated papers\n)\nprint(\"âœ… ProcessingAndFilteringAgent created.\")\n\nbibliography_agent = Agent(\n    name=\"BibliographyAgent\", model=Gemini(model=\"gemini-2.5-flash-lite\"),\n    instruction=\"\"\"\n     You are a strict formatting engine. \n    1. Receive the 'filtered_papers_list'.\n    2. Format the list into a bibliography. If specified by the user, implement the preferred citation format. Else, default to APA.\n    3. Output ONLY the string returned by the tool. Do not add any conversational text.\n    \"\"\",\n    tools=[],\n    output_key=\"bibliography_text\",  # Stores just the refs\n)\nprint(\"âœ… Bibliography Agent created.\")\n\nsynthesis_agent = Agent(\n    name=\"SynthesisAgent\", model=Gemini(model=\"gemini-2.5-flash-lite\"),\n    instruction=\"\"\"\n    You are a technical writer. \n    1. Read the 'filtered_papers_list' to write a literature review (3 themes) along with research gaps.\n    2. Read the 'bibliography_text' provided by the previous agent.\n    3. Append the bibliography text EXACTLY as is to the end of your review.\n    \"\"\",\n    tools=[],\n    output_key=\"final_literature_review\",\n)\n\nprint(\"âœ… Synthesis Agent created.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-29T11:43:49.789008Z","iopub.execute_input":"2025-11-29T11:43:49.789327Z","iopub.status.idle":"2025-11-29T11:43:49.798393Z","shell.execute_reply.started":"2025-11-29T11:43:49.789306Z","shell.execute_reply":"2025-11-29T11:43:49.797444Z"}},"outputs":[{"name":"stdout","text":"âœ… OrchestratorAgent created.\nâœ… SearchAndRetrievalAgent created.\nâœ… ProcessingAndFilteringAgent created.\nâœ… Bibliography Agent created.\nâœ… Synthesis Agent created.\n","output_type":"stream"}],"execution_count":53},{"cell_type":"code","source":"async def run_session(\n\n    runner_instance: Runner, user_queries: list[str] | str, session_id: str = \"default\"):\n    print(f\"\\n### Session: {session_id}\")\n\n    try:\n        session = await session_service.create_session(\n            app_name=APP_NAME, user_id=USER_ID, session_id=session_id\n        )\n\n    except:\n        session = await session_service.get_session(\n            app_name=APP_NAME, user_id=USER_ID, session_id=session_id\n        )\n\n    # Convert single query to list\n\n    if isinstance(user_queries, str):\n        user_queries = [user_queries]\n\n    # Process each query\n\n    for query in user_queries:\n        print(f\"\\nUser > {query}\")\n        query_content = types.Content(role=\"user\", parts=[types.Part(text=query)])\n\n        # Stream agent response\n        \n        async for event in runner_instance.run_async(\n            user_id=USER_ID, session_id=session.id, new_message=query_content\n        ):\n\n            if event.is_final_response() and event.content and event.content.parts:\n                text = event.content.parts[0].text\n                if text and text != \"None\":\n                    print(f\"Model: > {text}\")\n\nprint(\"âœ… Helper functions defined.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-29T11:43:49.799999Z","iopub.execute_input":"2025-11-29T11:43:49.801258Z","iopub.status.idle":"2025-11-29T11:43:49.817183Z","shell.execute_reply.started":"2025-11-29T11:43:49.801223Z","shell.execute_reply":"2025-11-29T11:43:49.816368Z"}},"outputs":[{"name":"stdout","text":"âœ… Helper functions defined.\n","output_type":"stream"}],"execution_count":54},{"cell_type":"code","source":"session_service = (InMemorySessionService())\nmemory_service = (InMemoryMemoryService())\n\nlit_agent = SequentialAgent(\n    name=\"LitReviewFlow\",\n    sub_agents=[\n        orchestrator_agent, \n        search_agent, \n        filtering_agent, \n        synthesis_agent,\n        bibliography_agent\n    ]\n)\n\n\nlit_review_runner = Runner(\n    agent=lit_agent, \n    app_name=APP_NAME,\n    session_service=session_service,\n    memory_service=memory_service\n)\n# \nprint(\"âœ… Runner configured with Session and Memory Services.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-29T11:43:49.818050Z","iopub.execute_input":"2025-11-29T11:43:49.818323Z","iopub.status.idle":"2025-11-29T11:43:49.835770Z","shell.execute_reply.started":"2025-11-29T11:43:49.818294Z","shell.execute_reply":"2025-11-29T11:43:49.834944Z"}},"outputs":[{"name":"stdout","text":"âœ… Runner configured with Session and Memory Services.\n","output_type":"stream"}],"execution_count":55},{"cell_type":"code","source":"response = await run_session(lit_review_runner, \"Why elephants don't get cancer and potential for cancer vaccines\", 'conversation-01')\nprint(response)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-29T11:43:49.837413Z","iopub.execute_input":"2025-11-29T11:43:49.837648Z","iopub.status.idle":"2025-11-29T11:45:19.221657Z","shell.execute_reply.started":"2025-11-29T11:43:49.837630Z","shell.execute_reply":"2025-11-29T11:45:19.220839Z"}},"outputs":[{"name":"stdout","text":"\n### Session: conversation-01\n\nUser > Why elephants don't get cancer and potential for cancer vaccines\n","output_type":"stream"},{"name":"stderr","text":"Warning: there are non-text parts in the response: ['function_call'], returning concatenated text result from text parts. Check the full candidates.content.parts accessor to get the full model response.\n","output_type":"stream"},{"name":"stdout","text":"Model: > I cannot fulfill this request. The `load_memory` function does not accept any arguments. If you'd like to load memory, please make the request again without any arguments.\nðŸ”‘ Auto-saving Orchestrator turn to MemoryService...\nModel: > This is a list of academic papers on elephants and cancer resistance, with a focus on the TP53 gene and its implications for cancer vaccines.\n\n*   **Title:** Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage in Humans\n    **Abstract:** Elephants exhibit a lower-than-expected cancer rate, potentially due to multiple copies of the TP53 gene. Elephant cells show a heightened apoptotic response to DNA damage compared to human cells, offering insights into cancer suppression mechanisms that could benefit human cancer risk reduction strategies. The study analyzed elephant genomes for cancer-related genes and compared DNA repair and apoptosis responses in elephant and human cells.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEHotBJbJ-X9XfKKiIRufTBf2XwaSgK73WyPLS2Rsz3aTNBpi5UudXnQzW0IUEJrXehopYm7exTIZiJECza9Iz2OKSo7G0O11L6igPK2_fMTJj8xw05p3gN1nf3uUjrg9k3JOsPmLXJl0M2CeQ=\n\n*   **Title:** Elephant genes could hold the key to avoiding cancers\n    **Abstract:** Scientists have modeled the cancer-suppressing p53 gene in elephants, revealing that their 20 unique p53 molecules are activated for increased sensitivity and response against carcinogenic conditions. This research has implications for developing cancer treatments in humans, offering new insights into molecular interactions that could reduce cancer susceptibility. Elephants have a significantly lower cancer mortality rate than humans, attributed to their multiple copies of the p53 gene.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQErwyC2m5lvwj_Ppi58OnLEB2GKsXg1rSB8_Tq1xK79oXu3Z7CMcWuFO4MXy5Sp0AYRk0sTnTFWoiHohuXEfVV7DSN0YgXXb2ugVEh6_9TWKVvvQW36ucueBta17UpwiAk27vZpxiiPsmwvEo2DYp1RGMtms1PHdeyiD0Hx0DHfDzuvssthXNYc8KlZv6tD\n\n*   **Title:** Why Elephants Rarely Get Cancer\n    **Abstract:** Research from the Huntsman Cancer Institute suggests elephants' low cancer rates are due to extra copies of the p53 gene, a known cancer inhibitor. Elephant cells also exhibit a more robust mechanism for eliminating damaged, potentially cancerous cells. These findings could lead to new cancer treatment strategies for humans, as elephants appear to have evolved effective cancer prevention mechanisms.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGdMkoIx4SoZmjCSKr2BBqUbH8GfK1vS4U9J95iEVvI_ZBejofOV0JIorBbEpuXlwJ_2jv4Efld-pMjB793dIahDxyEbVUueanZwx26ryvmnPTKh_T0541M1NpGMrsLYDvdP2Vd2OTsCZMUrixH3SS_MbvZhYPyGgh0-ac3_5_Lioub-IcCuv25iJpOphA=\n\n*   **Title:** How elephants evolved to beat cancer, and how we could too\n    **Abstract:** Elephants possess unique genetic variants that reduce their risk of tumors, explaining their unusually low cancer rates despite their large size and long lifespans. These findings could inform the development of new cancer therapies for humans. The research highlights that elephants have multiple copies of the p53 tumor-suppressing gene, which produces a protein that acts as a cell guard, halting cell division upon detecting DNA damage.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFA0vF1YlKWtx2TB7z35lvzyf_-MY_EsWuReWUTUOATop5gIvK_Dc5jFtBOU4ovWA8gIQtBigIn1HYZFSxlGfjgKhQ2BP0t0Te0pe0UZ__iY_YAZJKmGd9C4itJLJRoJ2WeIwVBxYWiGmUZ6ydKd3L6J7hRsRj5Ix8qy98Rs85clFc1XXs4bu8JeMyB7dKAbw==\n\n*   **Title:** Potential mechanisms for cancer resistance in elephants and comparative cellular response to DNA damage in humans\n    **Abstract:** Elephants exhibit a lower-than-expected cancer rate, potentially related to multiple copies of TP53. Compared to human cells, elephant cells demonstrate an increased apoptotic response following DNA damage. These findings suggest an evolutionary approach to understanding cancer suppression, with potential applications for human cancer prevention. The study analyzed cancer mortality across species and investigated elephant genomes for cancer-related genes, comparing DNA repair and apoptosis in elephant and human lymphocytes.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHIyPGNml9C-8XtF2fVZ0GfrnucwuICVAtKXOQxx2DyerKgZm4QM4oXiiEF6mcTh-XXAnABRGuHwoHRUI27fou_tST5Geymp6zH9kNDbiOzwLNU8XWh3-0yCtNuOMDQkokIANy5VZUPyoFfm0QUbRfm9pHxzF6RZeHtwq09jSpj6UISrs28OesOOBIrbmSCcxKFfAnj2q6Oo7wB\n\n*   **Title:** Why elephants rarely get cancer â€“ how evolution is helping unlock nature's potential to overcome cancer\n    **Abstract:** Elephants possess a natural resistance to cancer, linked to multiple copies of the TP53 gene, unlike humans who have only two. Elephant TP53 genes are evolved to be more effective, leading to damaged elephant cells self-destructing rather than trying to repair mutations, thus preventing cancer development. This research could inform the development of new cancer treatments by harnessing these natural defenses.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFjSsqXLnI8Q6uLIEiZVxLeHyqqgkeFGgDnoGMRgjtGXfUKgy9sxgAaNrPJ2OH_h22KI0egFOSuyP636kFjlAzV4E1DS10PvUDlrUM_axz-a6Jp9A_u0REXmMYvtTLG7wCa8h67KykflAb40j0qZpiwKAzC0lO3pfrZIknF4cMyu4H3wSYnC8ikAKrIwq9KKHxMV7G8IY-36QBnw3k2F6V-T_I0WWh9kPo0j0s2AS4-4LlN-MluZi-eNhTu8iQNYGpXSlvKIohMFNj1wHvqTQrixJ4xurr1L6sXSVexUGsILH-Oc-YMlQHlGLaW0QhlCy6q\n\n*   **Title:** What can elephants teach us about cancer?\n    **Abstract:** Elephants possess extra copies of genes, including TP53, that help fight cancer. Some of these genes are shared with other cancer-resistant animals, suggesting potential relevance for human cancer research. The multiple copies of TP53 in elephants may have evolved to protect sperm from heat damage, with cancer protection being a secondary benefit. This research explores how elephant genetics can inform human cancer treatments.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH5jkPi-SvFmilgUkkkgoGEuPln8yZRxl0M9CyTwFMEYc4U8nHwz9ifQO1k2o0XJ-NhvKKyCyi7yyxzdButmeRcVRUq4h3uHp0iJ7Xk4meiniD-HQ8MqVGyKlamouCpwkZFmde7jqbTcKd0pBMez4MO-mFe7_wIBCAjL66xCFE8fTc=\n\n*   **Title:** Rapid evolution of genes with anti-cancer functions during the origins of large bodies and cancer resistance in elephants\n    **Abstract:** Elephants, despite their size, have a low prevalence of cancer, attributed to mechanisms beyond just tumor suppressor gene duplication. Positively selected and rapidly evolving genes in elephants are enriched in pathways related to cell death, DNA repair, cell cycle regulation, and immune functions, all contributing to enhanced cancer resistance. These genes are promising candidates for understanding elephant-specific traits, including their molecular and cellular characteristics that improve cancer resistance.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGWF327rOYx4w-eS0Hh-dsOnK-UpVN-1SJTbrlqeBkJ35xjk9U-zJItsob7rWJZUgLByTc2Iu3i6y74CW9RC1gsh6U5YNvS6I34pItY5HXg1iNjMwCB7JIGP30V2AMikmIECvus\n\n*   **Title:** Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage in Humans.\n    **Abstract:** Elephants have a lower cancer mortality rate than humans, possibly due to multiple copies of the TP53 gene. Elephant lymphocytes show higher rates of p53-mediated apoptosis in response to DNA damage compared to human lymphocytes. These findings suggest that multiple TP53 copies contribute to cancer suppression in elephants and could inform approaches to cancer prevention in humans.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFe-KZHhNtDbedE5VueQps3f6PiXj2J69u0xKA3CPUPIDcAM55GcYT2N-HkP4OIYeMEwIrm_8JGj1t4sq9hoYJ3uVESLd3C5ddJQmBGlkJr_WSpmSM8YScBn_zVSN9rvl30u-plOTpqFx0qlCpu_Ru14a1vcr7fApPpvbijOhGdzmkfLHtCQ4yC2lIMhmA4psToRfNzau3turHsgGr3dARdcxXWfM82KyK7xgeOQBJBPAeV4F4K4uO6ai-NwzL2iBxKm9ZcQbtD1Vzb4Lo=\n\n*   **Title:** From Churchill to Elephants: The Role of Protective Genes against Cancer\n    **Abstract:** Elephants possess up to 20 isoforms of the TP53 gene, which interact with MDM2 to enhance their apoptotic response to DNA damage and suppress tumors. This genetic advantage contributes to their lower incidence of cancer. The research explores how these elephant TP53 genes could inspire innovative cancer prevention strategies for humans.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFqi_--l_3bVC_4sNsIK1ayjYxzANXfm8L5OEEujCWxpKEG4c0VQ-U3ciCGS6jBoHWcnN91zAa-4ByzqP5JjPWyC_LhU7lbgG4zc0t-u-ZqWeNXK3FkzrmA6kjo6BkIHeD6Mg==\n\n*   **Title:** Evolutionary Biology: How elephants beat cancer\n    **Abstract:** Elephants have significantly reduced their cancer risk by duplicating the TP53 tumor suppressor gene, resulting in multiple retrogenes (RTGs). This genomic adaptation, along with extra copies of the leukemia inhibitory factor (LIF), contributes to their low cancer rates, a phenomenon known as Peto's Paradox. The research provides a molecular basis for cancer resistance in elephants and potential avenues for developing cancer therapies.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEaM7C0GpJVgVtxCcqaNZg7nPiDV9BMZi4zP89zY8Z4ZCKlXK2uuN2nXM7UWlKUuLvfTQEwp8NdN-vnd3QW0jA0BUx3QRfLNMHQYcFgBvqOtia3py7i1uxBzBBlToUJE20Q-pHYVY6qCb6bd8k8L0-i0J4EdN4FQkOoVSC81udDtjV7BWXagNF7fzO3u6ImYQetAtxHn5-m54fygWw=\n\n*   **Title:** Rarity of cancer in elephants may help explain cancer in humans\n    **Abstract:** Elephants possess 40 copies of the TP53 gene, which suppresses tumor cells. Unlike humans, elephant cells tend to die when exposed to DNA-damaging substances, a safer approach than attempting repair, which can lead to mutations. These anti-cancer mechanisms in elephants, including enhanced DNA repair and cell death responses, offer insights for developing human cancer therapies.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEwlxfCXfVq8c_Hfwr9YBi6nF4FFG7sb9H_GmbahbVSf7NubKEh0IOsG2YRUsLDUFVF4wO6Ix6b0LqeyynchflIF82lzuJJ0Js_w6gUM1WNWqifWqCVgb-TeCtt-hGJOxYFsZhTBuTJYiQ7FdWBfzxHiuubsObHbE0cwPMAhWA65-9nzokNeTFe2ot_3aqv8KDOZPxm07RHcAchpizfVSJKrnVhl0lLHAQ-_Ak-HQl88rcLOPqHK3nIpNf0MF3wkv1UNtMMxBa24oH8lkvbrAlEeZb4J0DQVYFNeczdcR0SHcF0e-LWQn7KSexaIqQ=\n\n*   **Title:** Study: Elephants rarely get cancer--and that could boost human oncology research\n    **Abstract:** Elephants have 38 extra copies of the TP53 gene, a tumor suppressor, compared to humans' two copies. This genetic advantage may explain their low cancer mortality rate (4.8%). Elephant white blood cells, when exposed to DNA damage, self-destruct, likely a p53-mediated response. This research in comparative oncology could lead to new treatment strategies for human cancers.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF30IBEFUX7JIA4YhDLnuzdPU51kfJv4tOpmeElpD6gw-DJDoZpzTbF-ntK6BHpoOoKZ5emXmPY0XzEGJJ-1kVkJ9LUqgNm6CoWgxFHu604A6ZJLn8tSYWP2obTAm6JHP0zmDOA058ZD_YQKesvnihrU8bhQQbdrsSy7lj10lBD7bVzfzrLNN1c3QJi1vOdYUMiNepEs0sx310cpinECrW7iR_f5N69Lf8hy8TPcBJS\n\n*   **Title:** Scientists develop vaccine to protect young elephants from potentially lethal herpesvirus\n    **Abstract:** A novel vaccine has been developed to protect young elephants from Elephant Endotheliotropic Herpesvirus (EEHV), a potentially lethal virus. The vaccine aims to bolster the elephant's immune system's ability to fight the virus, rather than prevent infection entirely, as complete prevention is difficult for herpesviruses. This technology could be adapted for use in other animals and for treating other viruses.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEvZXSSVzkaeEvdtQguZS0p8o9pYss7o52Z-FVTlIutoX6LLFtdJFK2C8DrxALlHbYDnml9Odr5I3JKfVBUqGwPLs6E7xPZydriIt7TfAPeLN1LNxpGeaRTVsP4BuS8P6EASQuLJify-jYM5SYfBSRvwB7r4vpksyyeccEVEmexMYJrzWE8ahdTZFeDE7YEFVz4C7K1HebSD8Z9GY5bFQitux7XqfR_YNYZ2rxJ2F2TY_3KwS_d7dO6IyUr0g==\n","output_type":"stream"},{"name":"stderr","text":"Unclosed client session\nclient_session: <aiohttp.client.ClientSession object at 0x7fb2495f6a90>\nUnclosed client session\nclient_session: <aiohttp.client.ClientSession object at 0x7fb2493b6c90>\nUnclosed client session\nclient_session: <aiohttp.client.ClientSession object at 0x7fb2493867d0>\nUnclosed client session\nclient_session: <aiohttp.client.ClientSession object at 0x7fb26dd0aa90>\nUnclosed client session\nclient_session: <aiohttp.client.ClientSession object at 0x7fb2494ead90>\nWarning: there are non-text parts in the response: ['function_call', 'function_call', 'function_call', 'function_call', 'function_call', 'function_call', 'function_call', 'function_call', 'function_call', 'function_call', 'function_call', 'function_call', 'function_call', 'function_call'], returning concatenated text result from text parts. Check the full candidates.content.parts accessor to get the full model response.\n","output_type":"stream"},{"name":"stdout","text":"Model: > ## Literature Review: Elephant Cancer Resistance and Implications for Human Oncology\n\nThe remarkable resistance of elephants to cancer, despite their large size and long lifespans, has become a significant area of research, offering profound insights into cancer suppression mechanisms and potential avenues for human cancer therapies and vaccines. This review synthesizes the current understanding of elephant cancer resistance, focusing on genetic factors, cellular responses to DNA damage, and the broader implications for oncology.\n\n### Theme 1: The Role of TP53 Gene Duplication and Isoforms\n\nA recurring and central theme in the literature is the significant role of multiple copies and variants of the TP53 gene in elephant cancer resistance. Unlike humans, who possess two copies of TP53, elephants have evolved to have numerous copies, with some studies reporting up to 40 copies. This genetic redundancy appears to be a primary defense against cancer development. The TP53 gene produces a protein that acts as a crucial cell guard, halting cell division when DNA damage is detected. The increased number of TP53 copies in elephants likely ensures a more robust and sensitive response to DNA damage, effectively preventing the accumulation of mutations that could lead to cancer. Furthermore, research suggests that elephants may possess up to 20 distinct TP53 isoforms or molecules. These unique variants, when interacting with other proteins like MDM2, are activated for increased sensitivity and a heightened response against carcinogenic conditions, further bolstering their tumor-suppressing capabilities.\n\n### Theme 2: Enhanced Cellular Response to DNA Damage: Apoptosis and Cell Death\n\nBeyond gene duplication, elephant cells exhibit a distinctly different and more effective cellular response to DNA damage compared to human cells. When exposed to DNA-damaging agents, elephant cells, particularly lymphocytes, demonstrate a heightened propensity for apoptosis (programmed cell death). This robust apoptotic mechanism ensures that damaged or potentially cancerous cells are eliminated swiftly and efficiently, preventing them from undergoing mutations or uncontrolled proliferation. In contrast, human cells may attempt to repair DNA damage, a process that, while sometimes successful, can also introduce new mutations and inadvertently contribute to cancer development. This difference in cellular strategy â€“ prioritizing self-destruction of damaged cells over repair â€“ is a critical factor in the elephant's low cancer incidence.\n\n### Theme 3: Broader Evolutionary Adaptations and Potential for Cancer Vaccines\n\nThe mechanisms of cancer resistance in elephants extend beyond TP53. Research indicates that positively selected and rapidly evolving genes in elephants are enriched in pathways associated with cell death, DNA repair, cell cycle regulation, and immune functions. These broader genetic adaptations contribute to an overall enhanced capacity for cancer resistance. Some of these protective genes are shared with other cancer-resistant animals, suggesting conserved evolutionary strategies. While the primary focus of this literature is on genetic and cellular mechanisms, one paper touches upon the development of a vaccine for elephants against Elephant Endotheliotropic Herpesvirus (EEHV). While this vaccine is targeted at a viral pathogen and not cancer directly, the approach of bolstering the elephant's immune system to fight disease is a relevant concept. The success of such vaccine development in elephants could potentially inform strategies for other animal health issues and, more broadly, inspire innovative approaches to cancer prevention or treatment in humans, perhaps through enhancing the body's natural defenses.\n\n### Research Gaps\n\nWhile the literature provides a strong foundation for understanding elephant cancer resistance, several research gaps remain:\n\n*   **Comprehensive understanding of TP53 isoforms:** While the existence of multiple TP53 isoforms is noted, a detailed characterization of their specific functions, interactions, and differential regulation in response to various carcinogens is needed. Understanding how these isoforms synergize with each other and with other cellular components is crucial.\n*   **Mechanisms beyond TP53:** Although TP53 is a central player, the role of other rapidly evolving genes and pathways identified in elephant cancer resistance requires further in-depth investigation. The interplay between these genetic factors and their collective contribution to cancer suppression needs to be elucidated.\n*   **Translational application to human cancer vaccines:** The existing literature primarily focuses on understanding natural cancer resistance in elephants. There is a significant gap in research directly exploring how these elephant-specific mechanisms could be translated into tangible human cancer vaccines or therapies. While the concept of leveraging natural defenses is promising, the specific biological pathways and targets for therapeutic intervention remain to be fully defined and tested.\n*   **Comparative cellular dynamics in vivo:** Most studies compare cellular responses *in vitro*. Further research is needed to understand how these enhanced apoptotic and DNA repair mechanisms function within the complex *in vivo* environment of an elephant and how this contrasts with human physiology.\n*   **The role of LIF and other genes:** The mention of extra copies of leukemia inhibitory factor (LIF) and other genes involved in cell death, DNA repair, and immune functions warrants more detailed exploration to understand their specific contributions to cancer resistance.\n\n## Bibliography\n\n*   **Title:** Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage in Humans\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEHotBJbJ-X9XfKKiIRufTBf2XwaSgK73WyPLS2Rsz3aTNBpi5UudXnQzW0IUEJrXehopYm7exTIZiJECza9Iz2OKSo7G0O11L6igPK2_fMTJj8xw05p3gN1nf3uUjrg9k3JOsPmLXJl0M2CeQ=\n\n*   **Title:** Elephant genes could hold the key to avoiding cancers\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQErwyC2m5lvwj_Ppi58OnLEB2GKsXg1rSB8_Tq1xK79oXu3Z7CMcWuFO4MXy5Sp0AYRk0sTnTFWoiHohuXEfVV7DSN0YgXXb2ugVEh6_9TWKVvvQW36ucueBta17UpwiAk27vZpxiiPsmwvEo2DYp1RGMtms1PHdeyiD0Hx0DHfDzuvssthXNYc8KlZv6tD\n\n*   **Title:** Why Elephants Rarely Get Cancer\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGdMkoIx4SoZmjCSKr2BBqUbH8GfK1vS4U9J95iEVvI_ZBejofOV0JIorBbEpuXlwJ_2jv4Efld-pMjB793dIahDxyEbVUueanZwx26ryvmnPTKh_T0541M1NpGMrsLYDvdP2Vd2OTsCZMUrixH3SS_MbvZhYPyGgh0-ac3_5_Lioub-IcCuv25iJpOphA=\n\n*   **Title:** How elephants evolved to beat cancer, and how we could too\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFA0vF1YlKWtx2TB7z35lvzyf_-MY_EsWuReWUTUOATop5gIvK_Dc5jFtBOU4ovWA8gIQtBigIn1HYZFSxlGfjgKhQ2BP0t0Te0pe0UZ__iY_YAZJKmGd9C4itJLJRoJ2WeIwVBxYWiGmUZ6ydKd3L6J7hRsRj5Ix8qy98Rs85clFc1XXs4bu8JeMyB7dKAbw==\n\n*   **Title:** Potential mechanisms for cancer resistance in elephants and comparative cellular response to DNA damage in humans\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHIyPGNml9C-8XtF2fVZ0GfrnucwuICVAtKXOQxx2DyerKgZm4QM4oXiiEF6mcTh-XXAnABRGuHwoHRUI27fou_tST5Geymp6zH9kNDbiOzwLNU8XWh3-0yCtNuOMDQkokIANy5VZUPyoFfm0QUbRfm9pHxzF6RZeHtwq09jSpj6UISrs28OesOOBIrbmSCcxKFfAnj2q6Oo7wB\n\n*   **Title:** Why elephants rarely get cancer â€“ how evolution is helping unlock nature's potential to overcome cancer\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFjSsqXLnI8Q6uLIEiZVxLeHyqqgkeFGgDnoGMRgjtGXfUKgy9sxgAaNrPJ2OH_h22KI0egFOSuyP636kFjlAzV4E1DS10PvUDlrUM_axz-a6Jp9A_u0REXmMYvtTLG7wCa8h67KykflAb40j0qZpiwKAzC0lO3pfrZIknF4cMyu4H3wSYnC8ikAKrIwq9KKHxMV7G8IY-36QBnw3k2F6V-T_I0WWh9kPo0j0s2AS4-4LlN-MluZi-eNhTu8iQNYGpXSlvKIohMFNj1wHvqTQrixJ4xurr1L6sXSVexUGsILH-Oc-YMlQHlGLaW0QhlCy6q\n\n*   **Title:** What can elephants teach us about cancer?\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH5jkPi-SvFmilgUkkkgoGEuPln8yZRxl0M9CyTwFMEYc4U8nHwz9ifQO1k2o0XJ-NhvKKyCyi7yyxzdButmeRcVRUq4h3uHp0iJ7Xk4meiniD-HQ8MqVGyKlamouCpwkZFmde7jqbTcKd0pBMez4MO-mFe7_wIBCAjL66xCFE8fTc=\n\n*   **Title:** Rapid evolution of genes with anti-cancer functions during the origins of large bodies and cancer resistance in elephants\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGWF327rOYx4w-eS0Hh-dsOnK-UpVN-1SJTbrlqeBkJ35xjk9U-zJItsob7rWJZUgLByTc2Iu3i6y74CW9RC1gsh6U5YNvS6I34pItY5HXg1iNjMwCB7JIGP30V2AMikmIECvus\n\n*   **Title:** Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage in Humans.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFe-KZHhNtDbedE5VueQps3f6PiXj2J69u0xKA3CPUPIDcAM55GcYT2N-HkP4OIYeMEwIrm_8JGj1t4sq9hoYJ3uVESLd3C5ddJQmBGlkJr_WSpmSM8YScBn_zVSN9rvl30u-plOTpqFx0qlCpu_Ru14a1vcr7fApPpvbijOhGdzmkfLHtCQ4yC2lIMhmA4psToRfNzau3turHsgGr3dARdcxXWfM82KyK7xgeOQBJBPAeV4F4K4uO6ai-NwzL2iBxKm9ZcQbtD1Vzb4Lo=\n\n*   **Title:** From Churchill to Elephants: The Role of Protective Genes against Cancer\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFqi_--l_3bVC_4sNsIK1ayjYxzANXfm8L5OEEujCWxpKEG4c0VQ-U3ciCGS6jBoHWcnN91zAa-4ByzqP5JjPWyC_LhU7lbgG4zc0t-u-ZqWeNXK3FkzrmA6kjo6BkIHeD6Mg==\n\n*   **Title:** Evolutionary Biology: How elephants beat cancer\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEaM7C0GpJVgVtxCcqaNZg7nPiDV9BMZi4zP89zY8Z4ZCKlXK2uuN2nXM7UWlKUuLvfTQEwp8NdN-vnd3QW0jA0BUx3QRfLNMHQYcFgBvqOtia3py7i1uxBzBBlToUJE20Q-pHYVY6qCb6bd8k8L0-i0J4EdN4FQkOoVSC81udDtjV7BWXagNF7fzO3u6ImYQetAtxHn5-m54fygWw=\n\n*   **Title:** Rarity of cancer in elephants may help explain cancer in humans\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEwlxfCXfVq8c_Hfwr9YBi6nF4FFG7sb9H_GmbahbVSf7NubKEh0IOsG2YRUsLDUFVF4wO6Ix6b0LqeyynchflIF82lzuJJ0Js_w6gUM1WNWqifWqCVgb-TeCtt-hGJOxYFsZhTBuTJYiQ7FdWBfzxHiuubsObHbE0cwPMAhWA65-9nzokNeTFe2ot_3aqv8KDOZPxm07RHcAchpizfVSJKrnVhl0lLHAQ-_Ak-HQl88rcLOPqHK3nIpNf0MF3wkv1UNtMMxBa24oH8lkvbrAlEeZb4J0DQVYFNeczdcR0SHcF0e-LWQn7KSexaIqQ=\n\n*   **Title:** Study: Elephants rarely get cancer--and that could boost human oncology research\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF30IBEFUX7JIA4YhDLnuzdPU51kfJv4tOpmeElpD6gw-DJDoZpzTbF-ntK6BHpoOoKZ5emXmPY0XzEGJJ-1kVkJ9LUqgNm6CoWgxFHu604A6ZJLn8tSYWP2obTAm6JHP0zmDOA058ZD_YQKesvnihrU8bhQQbdrsSy7lj10lBD7bVzfzrLNN1c3QJi1vOdYUMiNepEs0sx310cpinECrW7iR_f5N69Lf8hy8TPcBJS\n\n*   **Title:** Scientists develop vaccine to protect young elephants from potentially lethal herpesvirus\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEvZXSSVzkaeEvdtQguZS0p8o9pYss7o52Z-FVTlIutoX6LLFtdJFK2C8DrxALlHbYDnml9Odr5I3JKfVBUqGwPLs6E7xPZydriIt7TfAPeLN1LNxpGeaRTVsP4BuS8P6EASQuLJify-jYM5SYfBSRvwB7r4vpksyyeccEVEmexMYJrzWE8ahdTZFeDE7YEFVz4C7K1HebSD8Z9GY5bFQitux7XqfR_YNYZ2rxJ2F2TY_3KwS_d7dO6IyUr0g==\nModel: > *   **Title:** Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage in Humans. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFe-KZHhNtDbedE5VueQps3f6PiXj2J69u0xKA3CPUPIDcAM55GcYT2N-HkP4OIYeMEwIrm_8JGj1t4sq9hoYJ3uVESLd3C5ddJQmBGlkJr_WSpmSM8YScBn_zVSN9rvl30u-plOTpqFx0qlCpu_Ru14a1vcr7fApPpvbijOhGdzmkfLHtCQ4yC2lIMhmA4psToRfNzau3turHsgGr3dARdcxXWfM82KyK7xgeOQBJBPAeV4F4K4uO6ai-NwzL2iBxKm9ZcQbtD1Vzb4Lo=\n*   **Title:** Rarity of cancer in elephants may help explain cancer in humans. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEwlxfCXfVq8c_Hfwr9YBi6nF4FFG7sb9H_GmbahbVSf7NubKEh0IOsG2YRUsLDUFVF4wO6Ix6b0LqeyynchflIF82lzuJJ0Js_w6gUM1WNWqifWqCVgb-TeCtt-hGJOxYFsZhTBuTJYiQ7FdWBfzxHiuubsObHbE0cwPMAhWA65-9nzokNeTFe2ot_3aqv8KDOZPxm07RHcAchpizfVSJKrnVhl0lLHAQ-_Ak-HQl88rcLOPqHK3nIpNf0MF3wkv1UNtMMxBa24oH8lkvbrAlEeZb4J0DQVYFNeczdcR0SHcF0e-LWQn7KSexaIqQ=\n*   **Title:** Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage in Humans. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEHotBJbJ-X9XfKKiIRufTBf2XwaSgK73WyPLS2Rsz3aTNBpi5UudXnQzW0IUEJrXehopYm7exTIZiJECza9Iz2OKSo7G0O11L6igPK2_fMTJj8xw05p3gN1nf3uUjrg9k3JOsPmLXJl0M2CeQ=\n*   **Title:** Study: Elephants rarely get cancer--and that could boost human oncology research. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF30IBEFUX7JIA4YhDLnuzdPU51kfJv4tOpmeElpD6gw-DJDoZpzTbF-ntK6BHpoOoKZ5emXmPY0XzEGJJ-1kVkJ9LUqgNm6CoWgxFHu604A6ZJLn8tSYWP2obTAm6JHP0zmDOA058ZD_YQKesvnihrU8bhQQbdrsSy7lj10lBD7bVzfzrLNN1c3QJi1vOdYUMiNepEs0sx310cpinECrW7iR_f5N69Lf8hy8TPcBJS\n*   **Title:** Evolutionary Biology: How elephants beat cancer. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEaM7C0GpJVgVtxCcqaNZg7nPiDV9BMZi4zP89zY8Z4ZCKlXK2uuN2nXM7UWlKUuLvfTQEwp8NdN-vnd3QW0jA0BUx3QRfLNMHQYcFgBvqOtia3py7i1uxBzBBlToUJE20Q-pHYVY6qCb6bd8k8L0-i0J4EdN4FQkOoVSC81udDtjV7BWXagNF7fzO3u6ImYQetAtxHn5-m54fygWw=\n*   **Title:** Why elephants rarely get cancer â€“ how evolution is helping unlock nature's potential to overcome cancer. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFjSsqXLnI8Q6uLIEiZVxLeHyqqgkeFGgDnoGMRgjtGXfUKgy9sxgAaNrPJ2OH_h22KI0egFOSuyP636kFjlAzV4E1DS10PvUDlrUM_axz-a6Jp9A_u0REXmMYvtTLG7wCa8h67KykflAb40j0qZpiwKAzC0lO3pfrZIknF4cMyu4H3wSYnC8ikAKrIwq9KKHxMV7G8IY-36QBnw3k2F6V-T_I0WWh9kPo0j0s2AS4-4LlN-MluZi-eNhTu8iQNYGpXSlvKIohMFNj1wHvqTQrixJ4xurr1L6sXSVexUGsILH-Oc-YMlQHlGLaW0QhlCy6q\n*   **Title:** Rapid evolution of genes with anti-cancer functions during the origins of large bodies and cancer resistance in elephants. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGWF327rOYx4w-eS0Hh-dsOnK-UpVN-1SJTbrlqeBkJ35xjk9U-zJItsob7rWJZUgLByTc2Iu3i6y74CW9RC1gsh6U5YNvS6I34pItY5HXg1iNjMwCB7JIGP30V2AMikmIECvus\n*   **Title:** What can elephants teach us about cancer?. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH5jkPi-SvFmilgUkkkgoGEuPln8yZRxl0M9CyTwFMEYc4U8nHwz9ifQO1k2o0XJ-NhvKKyCyi7yyxzdButmeRcVRUq4h3uHp0iJ7Xk4meiniD-HQ8MqVGyKlamouCpwkZFmde7jqbTcKd0pBMez4MO-mFe7_wIBCAjL66xCFE8fTc=\n*   **Title:** How elephants evolved to beat cancer, and how we could too. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFA0vF1YlKWtx2TB7z35lvzyf_-MY_EsWuReWUTUOATop5gIvK_Dc5jFtBOU4ovWA8gIQtBigIn1HYZFSxlGfjgKhQ2BP0t0Te0pe0UZ__iY_YAZJKmGd9C4itJLJRoJ2WeIwVBxYWiGmUZ6ydKd3L6J7hRsRj5Ix8qy98Rs85clFc1XXs4bu8JeMyB7dKAbw==\n*   **Title:** Why Elephants Rarely Get Cancer. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGdMkoIx4SoZmjCSKr2BBqUbH8GfK1vS4U9J95iEVvI_ZBejofOV0JIorBbEpuXlwJ_2jv4Efld-pMjB793dIahDxyEbVUueanZwx26ryvmnPTKh_T0541M1NpGMrsLYDvdP2Vd2OTsCZMUrixH3SS_MbvZhYPyGgh0-ac3_5_Lioub-IcCuv25iJpOphA=\n*   **Title:** Potential mechanisms for cancer resistance in elephants and comparative cellular response to DNA damage in humans. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHIyPGNml9C-8XtF2fVZ0GfrnucwuICVAtKXOQxx2DyerKgZm4QM4oXiiEF6mcTh-XXAnABRGuHwoHRUI27fou_tST5Geymp6zH9kNDbiOzwLNU8XWh3-0yCtNuOMDQkokIANy5VZUPyoFfm0QUbRfm9pHxzF6RZeHtwq09jSpj6UISrs28OesOOBIrbmSCcxKFfAnj2q6Oo7wB\n*   **Title:** Elephant genes could hold the key to avoiding cancers. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQErwyC2m5lvwj_Ppi58OnLEB2GKsXg1rSB8_Tq1xK79oXu3Z7CMcWuFO4MXy5Sp0AYRk0sTnTFWoiHohuXEfVV7DSN0YgXXb2ugVEh6_9TWKVvvQW36ucueBta17UpwiAk27vZpxiiPsmwvEo2DYp1RGMtms1PHdeyiD0Hx0DHfDzuvssthXNYc8KlZv6tD\n*   **Title:** From Churchill to Elephants: The Role of Protective Genes against Cancer. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFqi_--l_3bVC_4sNsIK1ayjYxzANXfm8L5OEEujCWxpKEG4c0VQ-U3ciCGS6jBoHWcnN91zAa-4ByzqP5JjPWyC_LhU7lbgG4zc0t-u-ZqWeNXK3FkzrmA6kjo6BkIHeD6Mg==\n*   **Title:** Scientists develop vaccine to protect young elephants from potentially lethal herpesvirus. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEvZXSSVzkaeEvdtQguZS0p8o9pYss7o52Z-FVTlIutoX6LLFtdJFK2C8DrxALlHbYDnml9Odr5I3JKfVBUqGwPLs6E7xPZydriIt7TfAPeLN1LNxpGeaRTVsP4BuS8P6EASQuLJify-jYM5SYfBSRvwB7r4vpksyyeccEVEmexMYJrzWE8ahdTZFeDE7YEFVz4C7K1HebSD8Z9GY5bFQitux7XqfR_YNYZ2rxJ2F2TY_3KwS_d7dO6IyUr0g==\nNone\n","output_type":"stream"}],"execution_count":56},{"cell_type":"code","source":"#Making use of model memory\nresponse = await run_session(lit_review_runner, \"Based on the last conversation, what other animals exhibit similar traits? Find research gaps\", 'conversation-01')\nprint(response)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-29T11:45:19.222541Z","iopub.execute_input":"2025-11-29T11:45:19.222833Z","iopub.status.idle":"2025-11-29T11:46:12.830200Z","shell.execute_reply.started":"2025-11-29T11:45:19.222811Z","shell.execute_reply":"2025-11-29T11:46:12.829455Z"}},"outputs":[{"name":"stdout","text":"\n### Session: conversation-01\n\nUser > Based on the last conversation, what other animals exhibit similar traits? Find research gaps\n","output_type":"stream"},{"name":"stderr","text":"Warning: there are non-text parts in the response: ['function_call'], returning concatenated text result from text parts. Check the full candidates.content.parts accessor to get the full model response.\n","output_type":"stream"},{"name":"stdout","text":"Model: > I'm sorry, but I cannot provide information on other animals exhibiting similar traits or identify research gaps based solely on the provided context. The previous conversation focused on elephants and their cancer resistance mechanisms, with a mention of potential applications for human cancer research. There was no discussion or data regarding other animal species with similar traits or specific research gaps beyond the general translational challenges to human oncology.\nðŸ”‘ Auto-saving Orchestrator turn to MemoryService...\nModel: > The field of comparative oncology is exploring why certain species, like elephants, exhibit remarkable resistance to cancer, a phenomenon often discussed in the context of Peto's Paradox. This paradox highlights that cancer rates do not strongly correlate with body size or the number of cells an organism possesses, suggesting that larger, longer-lived animals have evolved potent cancer suppression mechanisms.\n\n### Animals Exhibiting Similar Cancer Resistance Traits:\n\n*   **Whales:** Similar to elephants, whales, particularly large and long-lived species like the bowhead whale, show surprisingly low cancer rates despite their immense size and cellular count. Research on bowhead whales suggests highly efficient DNA repair mechanisms. While TP53 gene duplication, observed in elephants, has not been identified in whales, other tumor suppressor mechanisms are suspected.\n*   **Naked Mole Rats:** These subterranean rodents are highly resistant to cancer, even when experimentally induced. Their resistance is linked to unique mechanisms involving high concentrations of hyaluronan (HMM-HA) in their extracellular matrix, which exhibits anti-proliferative, anti-inflammatory, and anti-metastatic properties. They also possess robust tumor suppressor mechanisms and live significantly longer than other rodents.\n*   **Blind Mole Rats:** Like their naked mole rat cousins, blind mole rats also demonstrate significant cancer resistance.\n*   **Bats:** Several bat species show a low incidence of cancer. Their ability to fly has led to adaptations counteracting mitochondrial oxidative stress, which may also suppress the proliferation of energy-consuming cancer cells. The Rodrigues fruit bat is among the species identified as highly resistant to cancer.\n*   **Squirrels:** Long-lived squirrel species, such as grey squirrels, also display cancer resistance. Notably, they possess extremely high telomerase activity, a trait typically associated with tumorigenesis in humans, yet they remain cancer-resistant and long-lived.\n*   **Cows and Horses:** These large mammals are also noted for their cancer resistance, though specific mechanisms are still being investigated.\n*   **Dolphins and Porpoises:** Studies have identified common dolphins and common porpoises as species highly resistant to developing cancer.\n*   **Other Vertebrates:** A broad study identified over 90 vertebrate species with a high resistance to cancer, including common toads, Egyptian tortoises, and black-footed penguins.\n\n### Research Gaps:\n\nWhile significant progress has been made in understanding cancer resistance in various species, several research gaps remain:\n\n*   **Translational Mechanisms for Cancer Vaccines:** The most prominent gap is the direct translation of naturally evolved cancer resistance mechanisms into effective human cancer vaccines or therapies. While understanding these mechanisms is crucial, the precise pathways and targets for therapeutic intervention require further definition and experimental validation.\n*   **Comprehensive Characterization of TP53 Isoforms and Interactions:** For elephants, a deeper understanding of the specific functions and interactions of their numerous TP53 isoforms and their co-factors is needed to fully harness their tumor-suppressive potential.\n*   **Elucidation of Mechanisms Beyond TP53:** While TP53 is a key player, the roles of other genes and pathways involved in elephant and whale cancer resistance require more in-depth investigation to understand their collective contribution to cancer suppression.\n*   **Understanding Species-Specific Adaptations:** The diverse mechanisms of cancer resistance evolved in different species (e.g., hyaluronan in naked mole rats, enhanced DNA repair in whales) need to be fully characterized to identify conserved principles and species-unique strategies.\n*   **Bridging the Gap in Veterinary Oncology Research:** For species like dogs and cats, research into chemotherapy resistance is limited, particularly concerning mechanistic studies. A more robust comparative oncology framework is needed to leverage insights from human studies for veterinary medicine.\n*   **In Vivo Validation of Resistance Mechanisms:** Much of the current research involves *in vitro* studies. Understanding how these cancer resistance mechanisms function within the complex *in vivo* environment of different species is crucial for their application in human medicine.\n*   **Broader Data Collection on Cancer Prevalence:** While data on cancer prevalence in many non-model organisms is improving, more comprehensive and standardized data collection across a wider range of species is needed to fully validate Peto's Paradox and identify other cancer-resistant animals.\n*   **The Role of the Immune System:** The potential role of immune surveillance in cancer resistance across different species warrants further investigation.\nModel: > ```json\n[\n  {\n    \"title\": \"Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage in Humans\",\n    \"abstract\": \"Elephants exhibit a lower-than-expected cancer rate, potentially due to multiple copies of the TP53 gene. Elephant cells show a heightened apoptotic response to DNA damage compared to human cells, offering insights into cancer suppression mechanisms that could benefit human cancer risk reduction strategies. The study analyzed elephant genomes for cancer-related genes and compared DNA repair and apoptosis responses in elephant and human cells.\",\n    \"score\": 80\n  },\n  {\n    \"title\": \"Elephant genes could hold the key to avoiding cancers\",\n    \"abstract\": \"Scientists have modeled the cancer-suppressing p53 gene in elephants, revealing that their 20 unique p53 molecules are activated for increased sensitivity and response against carcinogenic conditions. This research has implications for developing cancer treatments in humans, offering new insights into molecular interactions that could reduce cancer susceptibility. Elephants have a significantly lower cancer mortality rate than humans, attributed to their multiple copies of the p53 gene.\",\n    \"score\": 80\n  },\n  {\n    \"title\": \"Why Elephants Rarely Get Cancer\",\n    \"abstract\": \"Research from the Huntsman Cancer Institute suggests elephants' low cancer rates are due to extra copies of the p53 gene, a known cancer inhibitor. Elephant cells also exhibit a more robust mechanism for eliminating damaged, potentially cancerous cells. These findings could lead to new cancer treatment strategies for humans, as elephants appear to have evolved effective cancer prevention mechanisms.\",\n    \"score\": 80\n  },\n  {\n    \"title\": \"How elephants evolved to beat cancer, and how we could too\",\n    \"abstract\": \"Elephants possess unique genetic variants that reduce their risk of tumors, explaining their unusually low cancer rates despite their large size and long lifespans. These findings could inform the development of new cancer therapies for humans. The research highlights that elephants have multiple copies of the p53 tumor-suppressing gene, which produces a protein that acts as a cell guard, halting cell division upon detecting DNA damage.\",\n    \"score\": 80\n  },\n  {\n    \"title\": \"Potential mechanisms for cancer resistance in elephants and comparative cellular response to DNA damage in humans\",\n    \"abstract\": \"Elephants exhibit a lower-than-expected cancer rate, potentially related to multiple copies of TP53. Compared to human cells, elephant cells demonstrate an increased apoptotic response following DNA damage. These findings suggest an evolutionary approach to understanding cancer suppression, with potential applications for human cancer prevention. The study analyzed cancer mortality across species and investigated elephant genomes for cancer-related genes, comparing DNA repair and apoptosis in elephant and human lymphocytes.\",\n    \"score\": 80\n  },\n  {\n    \"title\": \"Why elephants rarely get cancer â€“ how evolution is helping unlock nature's potential to overcome cancer\",\n    \"abstract\": \"Elephants possess a natural resistance to cancer, linked to multiple copies of the TP53 gene, unlike humans who have only two. Elephant TP53 genes are evolved to be more effective, leading to damaged elephant cells self-destructing rather than trying to repair mutations, thus preventing cancer development. This research could inform the development of new cancer treatments by harnessing these natural defenses.\",\n    \"score\": 80\n  },\n  {\n    \"title\": \"What can elephants teach us about cancer?\",\n    \"abstract\": \"Elephants possess extra copies of genes, including TP53, that help fight cancer. Some of these genes are shared with other cancer-resistant animals, suggesting potential relevance for human cancer research. The multiple copies of TP53 in elephants may have evolved to protect sperm from heat damage, with cancer protection being a secondary benefit. This research explores how elephant genetics can inform human cancer treatments.\",\n    \"score\": 80\n  },\n  {\n    \"title\": \"Rapid evolution of genes with anti-cancer functions during the origins of large bodies and cancer resistance in elephants\",\n    \"abstract\": \"Elephants, despite their size, have a low prevalence of cancer, attributed to mechanisms beyond just tumor suppressor gene duplication. Positively selected and rapidly evolving genes in elephants are enriched in pathways related to cell death, DNA repair, cell cycle regulation, and immune functions, all contributing to enhanced cancer resistance. These genes are promising candidates for understanding elephant-specific traits, including their molecular and cellular characteristics that improve cancer resistance.\",\n    \"score\": 80\n  },\n  {\n    \"title\": \"Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage in Humans.\",\n    \"abstract\": \"Elephants have a lower cancer mortality rate than humans, possibly due to multiple copies of the TP53 gene. Elephant lymphocytes show higher rates of p53-mediated apoptosis in response to DNA damage compared to human lymphocytes. These findings suggest that multiple TP53 copies contribute to cancer suppression in elephants and could inform approaches to cancer prevention in humans.\",\n    \"score\": 80\n  },\n  {\n    \"title\": \"From Churchill to Elephants: The Role of Protective Genes against Cancer\",\n    \"abstract\": \"Elephants possess up to 20 isoforms of the TP53 gene, which interact with MDM2 to enhance their apoptotic response to DNA damage and suppress tumors. This genetic advantage contributes to their lower incidence of cancer. The research explores how these elephant TP53 genes could inspire innovative cancer prevention strategies for humans.\",\n    \"score\": 80\n  },\n  {\n    \"title\": \"Evolutionary Biology: How elephants beat cancer\",\n    \"abstract\": \"Elephants have significantly reduced their cancer risk by duplicating the TP53 tumor suppressor gene, resulting in multiple retrogenes (RTGs). This genomic adaptation, along with extra copies of the leukemia inhibitory factor (LIF), contributes to their low cancer rates, a phenomenon known as Peto's Paradox. The research provides a molecular basis for cancer resistance in elephants and potential avenues for developing cancer therapies.\",\n    \"score\": 80\n  },\n  {\n    \"title\": \"Rarity of cancer in elephants may help explain cancer in humans\",\n    \"abstract\": \"Elephants possess 40 copies of the TP53 gene, which suppresses tumor cells. Unlike humans, elephant cells tend to die when exposed to DNA-damaging substances, a safer approach than attempting repair, which can lead to mutations. These anti-cancer mechanisms in elephants, including enhanced DNA repair and cell death responses, offer insights for developing human cancer therapies.\",\n    \"score\": 80\n  },\n  {\n    \"title\": \"Study: Elephants rarely get cancer--and that could boost human oncology research\",\n    \"abstract\": \"Elephants have 38 extra copies of the TP53 gene, a tumor suppressor, compared to humans' two copies. This genetic advantage may explain their low cancer mortality rate (4.8%). Elephant white blood cells, when exposed to DNA damage, self-destruct, likely a p53-mediated response. This research in comparative oncology could lead to new treatment strategies for human cancers.\",\n    \"score\": 80\n  }\n]\n```\nModel: > ## Comparative Oncology: Beyond Elephants to Other Cancer-Resistant Species and Future Research Directions\n\nThe remarkable cancer resistance observed in elephants, largely attributed to multiple copies of the TP53 gene and enhanced apoptotic responses, is not an isolated phenomenon. Comparative oncology reveals that other species have also evolved potent mechanisms to combat cancer, offering a broader perspective on evolution's strategies against this disease. Understanding these diverse adaptations can provide crucial insights into developing novel cancer therapies and vaccines for humans.\n\n### Other Animals Exhibiting Similar Cancer Resistance Traits\n\nPeto's Paradox, which posits that cancer incidence does not correlate with body size or cell count, is exemplified by several animal groups that exhibit surprisingly low cancer rates:\n\n*   **Marine Mammals:** Whales, particularly large and long-lived species like the **bowhead whale**, show a remarkably low incidence of cancer. Research points to highly efficient DNA repair mechanisms in these animals, although the specific TP53 gene duplication seen in elephants has not been identified. Similarly, **dolphins** and **porpoises**, including the common dolphin and common porpoise, have been identified as highly resistant to cancer.\n\n*   **Rodents with Exceptional Longevity and Resistance:** **Naked mole rats** and **blind mole rats** are well-known for their extraordinary cancer resistance. Their defense mechanisms are unique, involving high concentrations of hyaluronan in their extracellular matrix, which possesses anti-proliferative and anti-metastatic properties. They also possess robust tumor suppressor pathways and live significantly longer than other rodents.\n\n*   **Aerial Adaptations and Cancer Defense:** Several **bat** species, such as the Rodrigues fruit bat, demonstrate low cancer incidence. Their ability to fly may have led to adaptations that counteract mitochondrial oxidative stress, a factor that could also suppress the proliferation of energy-intensive cancer cells.\n\n*   **Unexpected Resistance in Common Mammals:** Large mammals like **cows** and **horses** are also noted for their cancer resistance, though the specific mechanisms are still under investigation. Even common **squirrels**, particularly long-lived species like grey squirrels, exhibit cancer resistance despite possessing high telomerase activity, a feature typically linked to cancer in humans.\n\n*   **A Broad Spectrum of Resistance:** Beyond these notable examples, a comprehensive study identified over 90 vertebrate species with high cancer resistance. This includes species as diverse as **common toads**, **Egyptian tortoises**, and **black-footed penguins**, underscoring that effective cancer suppression mechanisms have evolved across a wide range of the animal kingdom.\n\n### Research Gaps\n\nWhile the identification of cancer-resistant species is advancing, several critical research gaps need to be addressed to translate these natural defenses into human applications, particularly for cancer vaccines:\n\n*   **Translational Mechanisms for Cancer Vaccines:** The most significant gap is the direct translation of naturally evolved cancer resistance mechanisms into effective **human cancer vaccines** or therapies. While understanding these evolved defenses is crucial, the precise pathways, molecular targets, and immunological strategies that could be harnessed for therapeutic intervention remain largely undefined and require extensive experimental validation. The development of an elephant herpesvirus vaccine, while a positive step in veterinary medicine, highlights the complexity of vaccine development and the need for specific knowledge of the target disease and host.\n\n*   **Comprehensive Characterization of TP53 Isoforms and Interactions:** For elephants, a deeper understanding of the specific functions, interactions, and regulation of their numerous TP53 isoforms is needed. Identifying how these isoforms synergize and contribute to tumor suppression beyond simply increased copy number is crucial for any potential therapeutic targeting.\n\n*   **Elucidation of Mechanisms Beyond TP53:** While TP53 is a key player in elephants, the specific molecular underpinnings of cancer resistance in other species, such as the hyaluronan mechanisms in naked mole rats or the DNA repair pathways in whales, require more in-depth investigation. Understanding the collective contribution of these varied mechanisms is essential.\n\n*   **Understanding Species-Specific Adaptations:** The diverse strategies evolved by different species (e.g., extracellular matrix modifications, unique DNA repair enzymes, oxidative stress management) need to be fully characterized. This will allow researchers to identify conserved principles of cancer suppression that might be broadly applicable and to pinpoint species-unique strategies that could offer novel therapeutic avenues.\n\n*   **Bridging the Gap in Veterinary Oncology Research:** For companion animals like dogs and cats, research into chemotherapy resistance is limited, particularly concerning mechanistic studies. A more robust comparative oncology framework is needed to leverage insights from human and other animal studies for veterinary medicine, potentially leading to improved treatments for cancers in these species.\n\n*   **In Vivo Validation of Resistance Mechanisms:** Much of the current research is conducted *in vitro*. Understanding how these cancer resistance mechanisms function and are regulated within the complex *in vivo* environment of different species is crucial for the successful translation of these findings to human medicine.\n\n*   **Broader Data Collection on Cancer Prevalence:** While data on cancer prevalence in many non-model organisms is improving, more comprehensive and standardized data collection across a wider range of species is needed. This will not only help to further validate Peto's Paradox but also identify additional promising animal models for cancer resistance research.\n\n*   **The Role of the Immune System:** The potential role of immune surveillance in cancer resistance across different species warrants further investigation. How the immune systems of these cancer-resistant animals interact with nascent tumor cells, and whether this differs significantly from humans, could reveal novel targets for immunotherapy.\n\n## Bibliography\n\n*   **Title:** Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage in Humans.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFe-KZHhNtDbedE5VueQps3f6PiXj2J69u0xKA3CPUPIDcAM55GcYT2N-HkP4OIYeMEwIrm_8JGj1t4sq9hoYJ3uVESLd3C5ddJQmBGlkJr_WSpmSM8YScBn_zVSN9rvl30u-plOTpqFx0qlCpu_Ru14a1vcr7fApPpvbijOhGdzmkfLHtCQ4yC2lIMhmA4psToRfNzau3turHsgGr3dARdcxXWfM82KyK7xgeOQBJBPAeV4F4K4uO6ai-NwzL2iBxKm9ZcQbtD1Vzb4Lo=\n\n*   **Title:** Rarity of cancer in elephants may help explain cancer in humans.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEwlxfCXfVq8c_Hfwr9YBi6nF4FFG7sb9H_GmbahbVSf7NubKEh0IOsG2YRUsLDUFVF4wO6Ix6b0LqeyynchflIF82lzuJJ0Js_w6gUM1WNWqifWqCVgb-TeCtt-hGJOxYFsZhTBuTJYiQ7FdWBfzxHiuubsObHbE0cwPMAhWA65-9nzokNeTFe2ot_3aqv8KDOZPxm07RHcAchpizfVSJKrnVhl0lLHAQ-_Ak-HQl88rcLOPqHK3nIpNf0MF3wkv1UNtMMxBa24oH8lkvbrAlEeZb4J0DQVYFNeczdcR0SHcF0e-LWQn7KSexaIqQ=\n\n*   **Title:** Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage in Humans.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEHotBJbJ-X9XfKKiIRufTBf2XwaSgK73WyPLS2Rsz3aTNBpi5UudXnQzW0IUEJrXehopYm7exTIZiJECza9Iz2OKSo7G0O11L6igPK2_fMTJj8xw05p3gN1nf3uUjrg9k3JOsPmLXJl0M2CeQ=\n\n*   **Title:** Study: Elephants rarely get cancer--and that could boost human oncology research.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF30IBEFUX7JIA4YhDLnuzdPU51kfJv4tOpmeElpD6gw-DJDoZpzTbF-ntK6BHpoOoKZ5emXmPY0XzEGJJ-1kVkJ9LUqgNm6CoWgxFHu604A6ZJLn8tSYWP2obTAm6JHP0zmDOA058ZD_YQKesvnihrU8bhQQbdrsSy7lj10lBD7bVzfzrLNN1c3QJi1vOdYUMiNepEs0sx310cpinECrW7iR_f5N69Lf8hy8TPcBJS\n\n*   **Title:** Evolutionary Biology: How elephants beat cancer.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEaM7C0GpJVgVtxCcqaNZg7nPiDV9BMZi4zP89zY8Z4ZCKlXK2uuN2nXM7UWlKUuLvfTQEwp8NdN-vnd3QW0jA0BUx3QRfLNMHQYcFgBvqOtia3py7i1uxBzBBlToUJE20Q-pHYVY6qCb6bd8k8L0-i0J4EdN4FQkOoVSC81udDtjV7BWXagNF7fzO3u6ImYQetAtxHn5-m54fygWw=\n\n*   **Title:** Why elephants rarely get cancer â€“ how evolution is helping unlock nature's potential to overcome cancer.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFjSsqXLnI8Q6uLIEiZVxLeHyqqgkeFGgDnoGMRgjtGXfUKgy9sxgAaNrPJ2OH_h22KI0egFOSuyP636kFjlAzV4E1DS10PvUDlrUM_axz-a6Jp9A_u0REXmMYvtTLG7wCa8h67KykflAb40j0qZpiwKAzC0lO3pfrZIknF4cMyu4H3wSYnC8ikAKrIwq9KKHxMV7G8IY-36QBnw3k2F6V-T_I0WWh9kPo0j0s2AS4-4LlN-MluZi-eNhTu8iQNYGpXSlvKIohMFNj1wHvqTQrixJ4xurr1L6sXSVexUGsILH-Oc-YMlQHlGLaW0QhlCy6q\n\n*   **Title:** Rapid evolution of genes with anti-cancer functions during the origins of large bodies and cancer resistance in elephants.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGWF327rOYx4w-eS0Hh-dsOnK-UpVN-1SJTbrlqeBkJ35xjk9U-zJItsob7rWJZUgLByTc2Iu3i6y74CW9RC1gsh6U5YNvS6I34pItY5HXg1iNjMwCB7JIGP30V2AMikmIECvus\n\n*   **Title:** What can elephants teach us about cancer?.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH5jkPi-SvFmilgUkkkgoGEuPln8yZRxl0M9CyTwFMEYc4U8nHwz9ifQO1k2o0XJ-NhvKKyCyi7yyxzdButmeRcVRUq4h3uHp0iJ7Xk4meiniD-HQ8MqVGyKlamouCpwkZFmde7jqbTcKd0pBMez4MO-mFe7_wIBCAjL66xCFE8fTc=\n\n*   **Title:** How elephants evolved to beat cancer, and how we could too.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFA0vF1YlKWtx2TB7z35lvzyf_-MY_EsWuReWUTUOATop5gIvK_Dc5jFtBOU4ovWA8gIQtBigIn1HYZFSxlGfjgKhQ2BP0t0Te0pe0UZ__iY_YAZJKmGd9C4itJLJRoJ2WeIwVBxYWiGmUZ6ydKd3L6J7hRsRj5Ix8qy98Rs85clFc1XXs4bu8JeMyB7dKAbw==\n\n*   **Title:** Why Elephants Rarely Get Cancer.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGdMkoIx4SoZmjCSKr2BBqUbH8GfK1vS4U9J95iEVvI_ZBejofOV0JIorBbEpuXlwJ_2jv4Efld-pMjB793dIahDxyEbVUueanZwx26ryvmnPTKh_T0541M1NpGMrsLYDvdP2Vd2OTsCZMUrixH3SS_MbvZhYPyGgh0-ac3_5_Lioub-IcCuv25iJpOphA=\n\n*   **Title:** Potential mechanisms for cancer resistance in elephants and comparative cellular response to DNA damage in humans.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHIyPGNml9C-8XtF2fVZ0GfrnucwuICVAtKXOQxx2DyerKgZm4QM4oXiiEF6mcTh-XXAnABRGuHwoHRUI27fou_tST5Geymp6zH9kNDbiOzwLNU8XWh3-0yCtNuOMDQkokIANy5VZUPyoFfm0QUbRfm9pHxzF6RZeHtwq09jSpj6UISrs28OesOOBIrbmSCcxKFfAnj2q6Oo7wB\n\n*   **Title:** Elephant genes could hold the key to avoiding cancers.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQErwyC2m5lvwj_Ppi58OnLEB2GKsXg1rSB8_Tq1xK79oXu3Z7CMcWuFO4MXy5Sp0AYRk0sTnTFWoiHohuXEfVV7DSN0YgXXb2ugVEh6_9TWKVvvQW36ucueBta17UpwiAk27vZpxiiPsmwvEo2DYp1RGMtms1PHdeyiD0Hx0DHfDzuvssthXNYc8KlZv6tD\n\n*   **Title:** From Churchill to Elephants: The Role of Protective Genes against Cancer.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFqi_--l_3bVC_4sNsIK1ayjYxzANXfm8L5OEEujCWxpKEG4c0VQ-U3ciCGS6jBoHWcnN91zAa-4ByzqP5JjPWyC_LhU7lbgG4zc0t-u-ZqWeNXK3FkzrmA6kjo6BkIHeD6Mg==\n\n*   **Title:** Scientists develop vaccine to protect young elephants from potentially lethal herpesvirus.\n    **URL:** https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEvZXSSVzkaeEvdtQguZS0p8o9pYss7o52Z-FVTlIutoX6LLFtdJFK2C8DrxALlHbYDnml9Odr5I3JKfVBUqGwPLs6E7xPZydriIt7TfAPeLN1LNxpGeaRTVsP4BuS8P6EASQuLJify-jYM5SYfBSRvwB7r4vpksyyeccEVEmexMYJrzWE8ahdTZFeDE7YEFVz4C7K1HebSD8Z9GY5bFQitux7XqfR_YNYZ2rxJ2F2TY_3KwS_d7dO6IyUr0g==\nModel: > **Animals Exhibiting Similar Cancer Resistance Traits:**\n\n*   **Marine Mammals:** Whales (e.g., bowhead whale) and cetaceans (e.g., common dolphin, common porpoise) exhibit low cancer rates, attributed to efficient DNA repair mechanisms and other tumor suppressor pathways.\n*   **Rodents:** Naked mole rats and blind mole rats demonstrate exceptional cancer resistance due to unique extracellular matrix components (hyaluronan) and robust tumor suppressor pathways.\n*   **Bats:** Several bat species show low cancer incidence, potentially linked to adaptations for counteracting oxidative stress.\n*   **Large Mammals:** Cows, horses, and squirrels (e.g., grey squirrels) also display cancer resistance, with some exhibiting high telomerase activity without developing cancer.\n*   **Other Vertebrates:** A wide array of species, including common toads, Egyptian tortoises, and black-footed penguins, have been identified with high cancer resistance.\n\n**Research Gaps:**\n\n*   **Translational Mechanisms for Cancer Vaccines:** A significant gap exists in translating naturally evolved cancer resistance mechanisms from various species into effective human cancer vaccines or therapies. The precise pathways, molecular targets, and immunological strategies for therapeutic intervention require further definition and validation.\n*   **Comprehensive Characterization of TP53 Isoforms and Interactions:** A deeper understanding of the specific functions, interactions, and regulation of TP53 isoforms in elephants and other species is needed to fully leverage their tumor-suppressive potential.\n*   **Elucidation of Mechanisms Beyond TP53:** The molecular underpinnings of cancer resistance in species other than elephants, such as the hyaluronan mechanisms in naked mole rats or DNA repair pathways in whales, require more in-depth investigation to understand their collective contribution.\n*   **Understanding Species-Specific Adaptations:** A thorough characterization of the diverse cancer resistance strategies evolved by different species is crucial for identifying conserved principles and novel therapeutic avenues.\n*   **Veterinary Oncology Research:** There is a need for more mechanistic studies on chemotherapy resistance in companion animals like dogs and cats to improve treatments for their cancers.\n*   **In Vivo Validation of Resistance Mechanisms:** Understanding how cancer resistance mechanisms function within the complex *in vivo* environment of different species is critical for their translation to human medicine.\n*   **Broader Data Collection on Cancer Prevalence:** More comprehensive and standardized data collection on cancer prevalence across a wider range of species is needed to further validate Peto's Paradox and identify additional animal models for cancer research.\n*   **The Role of the Immune System:** The potential role of immune surveillance in cancer resistance across different species warrants further investigation to understand its contribution and potential for therapeutic targeting.\n\n## Bibliography\n\n*   **Title:** Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage in Humans. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFe-KZHhNtDbedE5VueQps3f6PiXj2J69u0xKA3CPUPIDcAM55GcYT2N-HkP4OIYeMEwIrm_8JGj1t4sq9hoYJ3uVESLd3C5ddJQmBGlkJr_WSpmSM8YScBn_zVSN9rvl30u-plOTpqFx0qlCpu_Ru14a1vcr7fApPpvbijOhGdzmkfLHtCQ4yC2lIMhmA4psToRfNzau3turHsgGr3dARdcxXWfM82KyK7xgeOQBJBPAeV4F4K4uO6ai-NwzL2iBxKm9ZcQbtD1Vzb4Lo=\n*   **Title:** Rarity of cancer in elephants may help explain cancer in humans. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEwlxfCXfVq8c_Hfwr9YBi6nF4FFG7sb9H_GmbahbVSf7NubKEh0IOsG2YRUsLDUFVF4wO6Ix6b0LqeyynchflIF82lzuJJ0Js_w6gUM1WNWqifWqCVgb-TeCtt-hGJOxYFsZhTBuTJYiQ7FdWBfzxHiuubsObHbE0cwPMAhWA65-9nzokNeTFe2ot_3aqv8KDOZPxm07RHcAchpizfVSJKrnVhl0lLHAQ-_Ak-HQl88rcLOPqHK3nIpNf0MF3wkv1UNtMMxBa24oH8lkvbrAlEeZb4J0DQVYFNeczdcR0SHcF0e-LWQn7KSexaIqQ=\n*   **Title:** Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage in Humans. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEHotBJbJ-X9XfKKiIRufTBf2XwaSgK73WyPLS2Rsz3aTNBpi5UudXnQzW0IUEJrXehopYm7exTIZiJECza9Iz2OKSo7G0O11L6igPK2_fMTJj8xw05p3gN1nf3uUjrg9k3JOsPmLXJl0M2CeQ=\n*   **Title:** Study: Elephants rarely get cancer--and that could boost human oncology research. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQF30IBEFUX7JIA4YhDLnuzdPU51kfJv4tOpmeElpD6gw-DJDoZpzTbF-ntK6BHpoOoKZ5emXmPY0XzEGJJ-1kVkJ9LUqgNm6CoWgxFHu604A6ZJLn8tSYWP2obTAm6JHP0zmDOA058ZD_YQKesvnihrU8bhQQbdrsSy7lj10lBD7bVzfzrLNN1c3QJi1vOdYUMiNepEs0sx310cpinECrW7iR_f5N69Lf8hy8TPcBJS\n*   **Title:** Evolutionary Biology: How elephants beat cancer. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEaM7C0GpJVgVtxCcqaNZg7nPiDV9BMZi4zP89zY8Z4ZCKlXK2uuN2nXM7UWlKUuLvfTQEwp8NdN-vnd3QW0jA0BUx3QRfLNMHQYcFgBvqOtia3py7i1uxBzBBlToUJE20Q-pHYVY6qCb6bd8k8L0-i0J4EdN4FQkOoVSC81udDtjV7BWXagNF7fzO3u6ImYQetAtxHn5-m54fygWw=\n*   **Title:** Why elephants rarely get cancer â€“ how evolution is helping unlock nature's potential to overcome cancer. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFjSsqXLnI8Q6uLIEiZVxLeHyqqgkeFGgDnoGMRgjtGXfUKgy9sxgAaNrPJ2OH_h22KI0egFOSuyP636kFjlAzV4E1DS10PvUDlrUM_axz-a6Jp9A_u0REXmMYvtTLG7wCa8h67KykflAb40j0qZpiwKAzC0lO3pfrZIknF4cMyu4H3wSYnC8ikAKrIwq9KKHxMV7G8IY-36QBnw3k2F6V-T_I0WWh9kPo0j0s2AS4-4LlN-MluZi-eNhTu8iQNYGpXSlvKIohMFNj1wHvqTQrixJ4xurr1L6sXSVexUGsILH-Oc-YMlQHlGLaW0QhlCy6q\n*   **Title:** Rapid evolution of genes with anti-cancer functions during the origins of large bodies and cancer resistance in elephants. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGWF327rOYx4w-eS0Hh-dsOnK-UpVN-1SJTbrlqeBkJ35xjk9U-zJItsob7rWJZUgLByTc2Iu3i6y74CW9RC1gsh6U5YNvS6I34pItY5HXg1iNjMwCB7JIGP30V2AMikmIECvus\n*   **Title:** What can elephants teach us about cancer?. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH5jkPi-SvFmilgUkkkgoGEuPln8yZRxl0M9CyTwFMEYc4U8nHwz9ifQO1k2o0XJ-NhvKKyCyi7yyxzdButmeRcVRUq4h3uHp0iJ7Xk4meiniD-HQ8MqVGyKlamouCpwkZFmde7jqbTcKd0pBMez4MO-mFe7_wIBCAjL66xCFE8fTc=\n*   **Title:** How elephants evolved to beat cancer, and how we could too. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFA0vF1YlKWtx2TB7z35lvzyf_-MY_EsWuReWUTUOATop5gIvK_Dc5jFtBOU4ovWA8gIQtBigIn1HYZFSxlGfjgKhQ2BP0t0Te0pe0UZ__iY_YAZJKmGd9C4itJLJRoJ2WeIwVBxYWiGmUZ6ydKd3L6J7hRsRj5Ix8qy98Rs85clFc1XXs4bu8JeMyB7dKAbw==\n*   **Title:** Why Elephants Rarely Get Cancer. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGdMkoIx4SoZmjCSKr2BBqUbH8GfK1vS4U9J95iEVvI_ZBejofOV0JIorBbEpuXlwJ_2jv4Efld-pMjB793dIahDxyEbVUueanZwx26ryvmnPTKh_T0541M1NpGMrsLYDvdP2Vd2OTsCZMUrixH3SS_MbvZhYPyGgh0-ac3_5_Lioub-IcCuv25iJpOphA=\n*   **Title:** Potential mechanisms for cancer resistance in elephants and comparative cellular response to DNA damage in humans. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHIyPGNml9C-8XtF2fVZ0GfrnucwuICVAtKXOQxx2DyerKgZm4QM4oXiiEF6mcTh-XXAnABRGuHwoHRUI27fou_tST5Geymp6zH9kNDbiOzwLNU8XWh3-0yCtNuOMDQkokIANy5VZUPyoFfm0QUbRfm9pHxzF6RZeHtwq09jSpj6UISrs28OesOOBIrbmSCcxKFfAnj2q6Oo7wB\n*   **Title:** Elephant genes could hold the key to avoiding cancers. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQErwyC2m5lvwj_Ppi58OnLEB2GKsXg1rSB8_Tq1xK79oXu3Z7CMcWuFO4MXy5Sp0AYRk0sTnTFWoiHohuXEfVV7DSN0YgXXb2ugVEh6_9TWKVvvQW36ucueBta17UpwiAk27vZpxiiPsmwvEo2DYp1RGMtms1PHdeyiD0Hx0DHfDzuvssthXNYc8KlZv6tD\n*   **Title:** From Churchill to Elephants: The Role of Protective Genes against Cancer. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFqi_--l_3bVC_4sNsIK1ayjYxzANXfm8L5OEEujCWxpKEG4c0VQ-U3ciCGS6jBoHWcnN91zAa-4ByzqP5JjPWyC_LhU7lbgG4zc0t-u-ZqWeNXK3FkzrmA6kjo6BkIHeD6Mg==\n*   **Title:** Scientists develop vaccine to protect young elephants from potentially lethal herpesvirus. URL: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEvZXSSVzkaeEvdtQguZS0p8o9pYss7o52Z-FVTlIutoX6LLFtdJFK2C8DrxALlHbYDnml9Odr5I3JKfVBUqGwPLs6E7xPZydriIt7TfAPeLN1LNxpGeaRTVsP4BuS8P6EASQuLJify-jYM5SYfBSRvwB7r4vpksyyeccEVEmexMYJrzWE8ahdTZFeDE7YEFVz4C7K1HebSD8Z9GY5bFQitux7XqfR_YNYZ2rxJ2F2TY_3KwS_d7dO6IyUr0g==\nNone\n","output_type":"stream"}],"execution_count":57}]}